›  Human Serum Albumin (HSA) is a large protein molecule that will be used extensively in all vaccine preparations as a carrier protein and in various disease conditions. Preliminary work on cloning and expression has been completed. The protein would be ready for commercialization by 2008-09.

›  Interferon Beta is a small therapeutic protein molecule that is used to treat the demyelinating disease of the central nervous system. It is not available in majority of the countries. At Sudershan Biotech, we have successfully cloned and expressed this protein. The production of Interferon Beta would commence by year 2008-09.

› Hepatitis C Vaccine is currently under development and the vaccine would be ready for commercialization by 2010-11.